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 It is known, that obesity and excess body mass significantly 
increases the risks of the emergence of various comorbidities, 
including bronchial asthma (BA). 
 Because of prevalence and medical social values BA and 
obesity belongs to global problem of health guarding. The level of 
morbidity and dissemination of BA increased recently among adult 
population, who are suffering because of obesity.  Obesity is a 
contributing factor of BA development. As explanations to the links 
between obesity and BA genetic predisposition has been considered. 
Obesity complicates the BA control and decreases positive results of 
the treatment. 
 The purpose of the investigation was studying the dependence 
between body mass index and Gln27Glu polymorphism ADRB2 
gene among patients with BA. 
 Materials and methods. 188 patients with light, moderate and 
severe persistent BA at the age from 18 till 70 have been examined. 
The diagnosis was made according to GINA recommendations 
(2011) and The Order of Ukraine Ministry of Health №128 
19.03.2007. The control group consisted of 87 almost healthy 
humans without allerhopatology without allergic history. 
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 Determination of allelic polymorphism of 1 exon β2 – 
adrenoceptor  Gln27Glu gene (rs1042714) was made using method 
of polymerase chain reaction with following analysis of restriction 
fragment length. 
 Results of investigations.  During the investigation it was 
defined that among patients with BA Gln27Gln genotype carriers 
average BMI was 24,9 ±0,5 kg/m2, the carriers of Gln27Glu 
genotype – 28,2 ± 0,8 kg/m2, the carriers of Glu27Glu genotype – 
34,5 ± 0,6 kg/m2 (p=0,0001). The average BMI was 23,4 ±0,4 kg/m2, 
Gln27Glu – 23.7 ± 0,5 kg/m2, Glu27Glu – 23,2 ±0,4 kg/m2 (p = 0,8) 
in almost healthy carriers of Gln27Gln Genotype. So, the patients 
with BA and Glu27Glu genotype have higher level of BMI (34,5 ± 
0,6 kg/m
2
). 
 Conclusions: The connection between Glu27Glu 
polymorphism ADRB2 gene and BMI among patients with BA have 
been found. Glu27Glu genotype is associated with obesity among 
patients with BA. The frequency of Glu27Glu genotype among 
patients with normal BMI was 69,7%, with overweight – 18.2 %, and 
with obesity – 12.1 %; carriers of Gln27Glu genotype – 53,8 %, 2,9 
% and 43,3 %; carriers Glu27Glu genotype – 9,1 %; 4.5 %; 86,4 %  
respectively (p = 0,0001). This tendency was not noticed (p = 0,8) in 
the control group. 
 
 
 
